title: Scenario of HIV/AIDS patients in a government hospital of Nepal.
abstract: BACKGROUND
  With the increase in the severity of immunosupression, due to HIV infection, there is increase in the flow of patients seeking care and support services. Antiretroviral drugs minimize chance of developing AIDS related opportunistic infection and therefore there would be the prolongation of life of the patients. The objectives of this study are to assess the chief complaints, major opportunistic infections, complications of ART and treatment outcome of hospital admitted HIV patients.
  
  
  METHODS
  A cross sectional study was carried out between December 2008 to May 2009 among 66 HIV patients undergoing indoor treatment in Seti Zonal Hospital, Dhangadhi.
  
  
  RESULTS
  Of the total cases, 36 (54.5%) were male and 30 (45.5%) were females with predominant age group of 31- 40 years (47%). About 24% of admitted patients had CD4 count less than 50/cu mm blood. Thirty five (53%) cases presented fever as the major clinical presentation of HIV/AIDS due to different opportunistic infections followed by cough (28.8%), loss of appetite (28.8%), weight loss (27.3%), and diarrhea (24.2%). Tuberculosis was found to be the major opportunistic infection accounting 27.3% followed by gastroenteritis (21.2%) and oral candidiasis (15.5%). Treatment outcome of hospital admitted patients showed the 83.3% recovery rate and 4.3% death rate.
  
  
  CONCLUSIONS
  Hospital admission was found to be efficient to treat the major opportunistic infections and management of ART hypersensitivity reactions. While tuberculosis was the leading opportunistic infection, the most common clinical manifestation was found to be fever among the admitted HIV/AIDS patients.
authors.affiliation: Department of Gastroenterology, NAMS, Bir Hospital, Kathmandu, Nepal. bidhan_dr2005@yahoo.com
authors.forename: B N
authors.initials: BN
authors.lastname: Poudel
authors.forename: G P
authors.initials: GP
authors.lastname: Dhungana
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000453:epidemiology / Q000517:prevention & control*; D000293:Adolescent; D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D058365:Candidiasis, Invasive; D002648:Child; D002675:Child, Preschool; D003430:Cross-Sectional Studies; D005260:Female; D015658:HIV Infections / Q000188:drug therapy / Q000453:epidemiology*; D006305:Health Status Indicators; D006779:Hospitals, Public / Q000706:statistics & numerical data*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008875:Middle Aged; D009390:Nepal / Q000453:epidemiology; D011014:Pneumonia / Q000453:epidemiology / Q000209:etiology; D012307:Risk Factors; D016896:Treatment Outcome; D014397:Tuberculosis, Pulmonary / Q000453:epidemiology / Q000209:etiology; D055815:Young Adult
chemical_list: D019380:Anti-HIV Agents